KLOW

A quad-peptide research formulation combining BPC-157, TB-500, GHK-Cu, and KPV, designed to engage complementary biological pathways in preclinical models. This combination has been studied for its coordinated effects on angiogenic signaling, cellular migration, extracellular matrix remodeling, and anti-inflammatory regulation, offering a multi-pathway approach to regenerative and recovery-focused research.

For Research Use Only.

Current Batch:

KLOW 80MG : IF-7209339